Reimbursement of Costs Payment. 4.1 LifeMap will provide funding to Mount Sinai to cover costs incurred by Mount Sinai in the conduct of the Development Activities in an initial amount totaling [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] Dollars as specified in the budget attached as Attachment B hereto, which is fully incorporated herein. The budget in Attachment B provides for an overhead charge (indirect cost rate) by Mount Sinai of [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] percent ([*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission]%) of the direct personnel salaries (excluding, for the avoidance of doubt, payroll taxes and benefits) of the Mount Sinai personnel and materials to be utilized for the Development Activities. The Parties acknowledge that Mount Sinai agrees to waive the first [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] Dollars (US$[*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission]) of such overhead charges (“Waived Funds”). Upon Mount Sinai’s request, LifeMap hereby agrees to provide written documentation to Mount Sinai that such Waived Funds are invested into LifeMap for the further development and commercialization of the LifeMap Navigator. For clarity, if funding has been provided to Mount Sinai in the amount of [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] Dollars (US$[*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission]) and such amount has been paid in personnel and materials costs, the overhead charge would be [*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission] percent ([*Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission]%) of [*Certain information has been omitted under a request for confidential...
Reimbursement of Costs Payment. 4.1 Sponsor shall pay the amounts specified in Attachment B in accordance with the schedule set forth therein. Institution shall apply all such amounts to its direct costs and mutually agreed upon overhead incurred in the conduct of the Sponsored Research. Sponsor acknowledges that the amounts set forth in Attachment B are only a good faith estimate of the costs to complete the Sponsored Research and not a guarantee of the cost to conduct the Sponsored Research. If at any time Institution determines that it will require additional funds for the Sponsored Research, it shall notify Sponsor and provide a good faith estimate and itemized budget of the additional amount. Sponsor shall not be liable for any costs in excess of the amount set forth in Attachment B unless it has agreed1 in writing to provide additional funds. In the event that Sponsor declines to provide such additional funding the parties shall promptly meet to determine how to achieve mutually agreed upon modified objectives. Sponsor shall make payments in advance to Institution in accordance with the payment schedule set forth in Attachment B. All payments shall clearly identify the Principal Investigator and Sponsored Research. All payments are to be made by wire transfer, banking information is as follows: Banking Information: Bank Name: […***…] Bank Address: […***…] ACH Coordinator: […***…] Account Title: […***…] Account Type: […***…] Account #: […***…] ABA Routing #: […***…] SWIFT CODE: […***…] CHIPS: […***…] Reference: […***…]
4.2 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this Agreement shall vest in Institution, and such equipment, animals, or materials shall remain the property of Institution following termination of this Agreement.
Reimbursement of Costs Payment. The SMO on behalf of the CLIENT shall reimburse the Investigational Site for all direct and indirect costs incurred in connection with the Clinical Trial up to ____________("Cost"). The SMO shall pay start-up costs which includes a non-refundable IRB/IEC fee, and/or clinical administration fees in the amount of -------------- which is payable upon signing of this agreement. The parties agree that the Cost is based upon the reasonable costs for similar studies at like institutions and Investigational Sites have not been induced to participate in this Clinical Trial based on inducements from CLIENT/SMO. The parties estimate that the Cost is sufficient to support the Clinical Trial, but if certain patient care costs are expected to be covered by insurance or another third party payers and such patient care costs are denied, CLIENT agrees to reimburse the SMO/Investigator for the patient care costs not covered by insurance or third party payer which are necessary to conduct the Clinical Trial. Investigational Sites may submit to SMO a revised budget requesting additional funds at such time as costs may reasonably be projected to exceed the Cost. The SMO will not be liable for any payment in excess of the Cost except upon CLIENT's written agreement. CLIENT shall make payments to SMO; the SMO in turn will make the payment in accordance with the Payment Schedule to the Investigator as attached in Appendix B and incorporated herein. SMO on behalf of the CLIENT will pay by Cheque to the Investigator's: Account No. PAN No: Pan card no: Which will be made payable to Investigator's and will be sent to: Dr.
Reimbursement of Costs Payment. 4.1 Sponsor shall reimburse Institution for an amount equal to its expenditures and reasonable overhead incurred in the conduct of the Sponsored Research in an amount not to exceed the total amount of $[***] as set forth in Attachment A. Sponsor acknowledges that this amount is a good faith estimate only and not a guarantee of the cost to conduct the Sponsored Research. If at any time Institution determines that it will require additional funds for the Sponsored Research due to a change in the scope of the Sponsored Research, it shall notify Sponsor and provide an estimate of the additional amount. Sponsor shall not be liable for any costs in excess of the amount of $[***] unless it has agreed in writing to provide additional funds.
4.2 Sponsor shall make payments in advance to Institution in accordance with the payment schedule set forth in Attachment A. All payments shall clearly identify the Principal Investigator and Sponsored Research. All payments are to be made by check payable in United States dollars, to “The Trustees of the University of Pennsylvania”, and sent to: Office of Research Services University of Pennsylvania P-221 Franklin Building 0000 Xxxxxx Xxxxxx Xxxxxxxxxxxx, XX 00000-0000 Attention: Executive Director 00-0000000 Institution Tax Identification Number
4.3 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this Agreement shall vest in Institution (excluding Project Materials and ICT-107 formulations), and such equipment, animals, or materials shall remain the property of Institution following termination of this Agreement.
Reimbursement of Costs Payment. 4.1 SPONSOR shall reimburse PENN for all direct and indirect costs incurred in the conduct of the SPONSORED RESEARCH in an amount not to exceed the total amount of $ 118,755 as set forth in Attachment A. SPONSOR acknowledges that this amount is a good faith estimate only and not a guarantee of the cost to conduct the SPONSORED RESEARCH. If at any time PENN determines that it will require additional funds for the SPONSORED RESEARCH, it shall notify SPONSOR and provide an estimate of the additional amount. SPONSOR shall not be liable for any costs in excess of the amount of $118,755 unless it has agreed in writing to provide additional funds.
4.2 SPONSOR shall make payments in advance to PENN in accordance with the payment schedule set forth in Attachment A. All payments shall clearly identify the PRINCIPAL INVESTIGATOR and SPONSORED RESEARCH. All payments are to be made by check payable in United States dollars, to "The Trustees of the University of Pennsylvania", and sent to: The University of Pennsylvania Office of Research Services P.O. Box 7777-W9535 Philadelphia, PA 19175
4.3 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this AGREEMENT shall vest in PENN, and such equipment, animals, or materials shall remain the property of PENN following termination of this AGREEMENT.
Reimbursement of Costs Payment. 3.1 SPONSOR shall reimburse STANFORD for all direct and indirect costs incurred by STANFORD in connection with the Clinical Trial up to ("Cost"). SPONSOR shall pay start-up costs which includes a non-refundable IRB fee, pharmacy set-up fee, and/or clinical administration fees in the amount of $ plus an IDC of % which is payable upon the signing of this Agreement. In addition, SPONSOR agrees to reimburse STANFORD the costs for advertising which shall not exceed $ . The Reimbursement Schedule for this clinical trial is as follows:
3.2 The parties agree that the Cost is based upon the reasonable costs for similar studies at like institutions in the same geographic area and STANFORD has not been induced to participate in this Clinical Trial based on inducements from SPONSOR. The parties estimate that the Cost is sufficient to support the Clinical Trial, but if certain patient care costs are expected to be covered by insurance or another third party payers and such patient care costs are denied, SPONSOR agrees to reimburse STANFORD for the patient care costs not covered by insurance or third party payer which are necessary to conduct the Clinical Trial. STANFORD may submit to SPONSOR a revised budget requesting additional funds at such time as costs may reasonably be projected to exceed the Cost. SPONSOR will not be liable for any payment in excess of the Cost except upon SPONSOR's written agreement.
3.3 SPONSOR shall make payments to STANFORD in accordance with the Payment Schedule attached as Exhibit B and incorporated herein.
3.4 SPONSOR will pay by wire transfer to: Xxxxx Fargo Bank 000 Xxxxxxxxxx Xxxxxx San Francisco, CA 94163 Account No. 4001-047349 ABA No. 000000000 or by checks, which will be made payable to Stanford University and will be sent to: By first class mail: By Express Mail Stanford University Stanford University Lockbox 44253 X.X. Xxx 00000 X/X Xxxxxxx Xxx Xxxxxxxxx, XX 00000-0000 00000 Xxxxxxx Xxxxxx, Suite 100 Attn: SPO # xxxx/PI Xxxxxxx, XX 00000 Tel: 000-000-0000
Reimbursement of Costs Payment. 4.1 Company agrees to reimburse UT for all direct and indirect costs incurred in the conduct of the Sponsored Research in an amount not to exceed the total amount of __________ dollars ($__________.00) (“Project Funds”) as set forth in Attachment B. Company acknowledges that this amount is a good faith estimate only and not a guarantee of the cost of the Sponsored Research. UT agrees that Project Funds will be spent substantially in accordance with the budget estimate set forth in Attachment B. If at any time UT determines that it will require additional funds for the Sponsored Research, it shall notify Company and provide an estimate of the additional amount. Company shall not be liable for any costs exceeding the Project Funds unless it has agreed in writing to provide additional funds.
4.2 Additional funds for expenditures (if applicable) agreed to by Company are set forth in Attachment C. UT shall provide Company with itemized statements reflecting the expenditure of such additional funds and Company shall reimburse UT for such additional expenditures of funds within thirty (30) days after receipt of such statement.
4.3 All payments are to be made by check payable in United States Dollars, to "The University of Toledo", and sent to the following address: Mr. Xxxx Xxxxxx Grants Accounting Office, MS455 The University of Toledo 0000 X. Xxxxxxxx Street Toledo, OH 43606
4.4 UT shall maintain accurate records and books of account relating to this Agreement in accordance with generally accepted accounting practices, and shall make such records and books available to Company upon reasonable notice during UT's normal business hours, but not more frequently than once each Calendar Year.
4.5 Company agrees that title to any equipment, supplies, or other materials made or acquired with funds provided under this Agreement shall vest in UT, and such items shall remain the property of UT following termination.
Reimbursement of Costs Payment. 4.1 Sponsor shall reimburse Institution for all direct and indirect costs incurred in the conduct of the Sponsored Research in an amount not to exceed the total amount of $ as set forth in Attachment A. Sponsor acknowledges that this amount is a good faith estimate only and not a guarantee of the cost to conduct the Sponsored Research. If at any time Institution determines that it will require additional funds for the Sponsored Research, it shall notify Sponsor and provide an estimate of the additional amount. Sponsor shall not be liable for any costs in excess of the amount of $ unless it has agreed in writing to provide additional funds.
4.2 Sponsor shall make payments in advance to Institution in accordance with the payment schedule set forth in Attachment A. All payments shall clearly identify the Principal Investigator and Sponsored Research. All payments are to be made by check payable in United States dollars, to "Xxxxxx Xxxxxxxxx University", and sent to: Xxxxxx Xxxxxxxxx University
4.3 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this Agreement shall vest in Institution, and such equipment, animals, or materials shall remain the property of Institution following termination of this Agreement. Institution retains ownership of all research notebooks.
Reimbursement of Costs Payment. 4.1 Sponsor shall reimburse Drexel for all direct and indirect costs incurred in the conduct of the Sponsored Research in an amount not to exceed the total amount of $ as set forth in Attachment
X. Xxxxxxx acknowledges that this amount is a good faith estimate only and not a guarantee of the cost to conduct the Sponsored Research. If at any time Drexel determines that it will require additional funds for the Sponsored Research, it shall notify Sponsor and provide an estimate of the additional amount. Sponsor shall not be responsible for any costs in excess of the amount of $ as set forth in Attachment A unless it has agreed in writing to provide additional funds.
4.2 Sponsor shall make payments in advance to Drexel in accordance with the payment schedule set forth in Attachment A. All payments are to be made by check payable in United States dollars, to “Drexel University", and sent to the address in Section 12.4.
4.3 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this Agreement shall vest in Drexel, and such equipment, animals, or materials shall remain the property of Drexel following termination of this Agreement.
Reimbursement of Costs Payment. 4.1 SPONSOR shall reimburse DUCOM for all direct and indirect costs incurred in the conduct of the SPONSORED RESEARCH in an amount not to exceed the total amount of $ as set forth in Attachment A. SPONSOR acknowledges that this amount is a good faith estimate only and not a guarantee of the cost to conduct the SPONSORED RESEARCH. If at any time DUCOM determines that it will require additional funds for the SPONSORED RESEARCH, it shall notify SPONSOR and provide an estimate of the additional amount. SPONSOR shall not be responsible for any costs in excess of the amount of $ as set forth in Attachment A unless it has agreed in writing to provide additional funds.
4.2 SPONSOR shall make payments in advance to DUCOM in accordance with the payment schedule set forth in Attachment A. All payments are to be made by check payable in United States dollars, to "Drexel University", and sent to the address in Section 11.4.
4.3 Title to any equipment, laboratory animals, or any other materials made or acquired with funds provided under this AGREEMENT shall vest in DUCOM, and such equipment, animals, or materials shall remain the property of DUCOM following termination of this AGREEMENT.
